{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Federal investigators said Tuesday that drug companies had repeatedly overcharged public hospitals and clinics for low-income patients, making them pay more than the maximum prices allowed by federal law. Such taxpayer-supported hospitals, community health centers and clinics for people with AIDS are supposed to have access to the government's best prices for outpatient drugs.", "headline": {"main": "Investigators Say Drug Makers Repeatedly Overcharged"}, "abstract": "Health and Human Services Department investigators say drug companies have repeatedly overcharged public hospitals and clinics for low-income people, charging prices that exceed legal maximums; report says Public Health Service should set out proposals for fines and civil penalties for violations of discount program established in 1992 law (S)", "print_page": "19", "word_count": 858, "_id": "4fd27e7b8eb7c8105d847226", "snippet": "Federal investigators said Tuesday that drug companies had repeatedly overcharged public hospitals and clinics for low-income patients, making them pay more than the maximum prices allowed by federal law.    Such taxpayer-supported hospitals,...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2004/06/30/us/investigators-say-drug-makers-repeatedly-overcharged.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "UNITED STATES"}, {"name": "organizations", "value": "HEALTH AND HUMAN SERVICES DEPARTMENT"}, {"name": "organizations", "value": "PUBLIC HEALTH SERVICE"}, {"name": "subject", "value": "FINES (PENALTIES)"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "LAW AND LEGISLATION"}, {"name": "subject", "value": "HOSPITALS"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Robert", "lastname": "PEAR"}], "original": "By ROBERT PEAR"}, "document_type": "article", "pub_date": "2004-06-30T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "Health & Fitness", "lead_paragraph": "Jump up and down, roar like Pavarotti, plunge into an ice-cold shower or, in emergencies, try all three at once. People do not lack for theories about how to stay awake, and there is certainly no shortage of options for the millions of cramming college students, occasional insomniacs and others overloaded by work, family and life who simply need to keep their eyes open for a few extra hours.", "headline": {"main": "When a Nap Is Not on the Program"}, "abstract": "Dr James K Wyatt, Rush University Medical Center, Chicago, sleep researcher, conducts study showing that caffeine, which is most widely used stimulant, can help people function for periods of time without proper sleep; holds that small regular doses of caffeine over time are most effective, but cannot ultimately replace sleep; other drugs used by people to stay awake discussed; photo (M)", "print_page": "6", "word_count": 854, "_id": "4fd27d558eb7c8105d844dd3", "snippet": "Jump up and down, roar like Pavarotti, plunge into an ice-cold shower or, in emergencies, try all three at once.     People do not lack for theories about how to stay awake, and there is certainly no shortage of options for the millions of cramming...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2004/06/29/health/when-a-nap-is-not-on-the-program.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "WYATT, JAMES K"}, {"name": "organizations", "value": "RUSH UNIVERSITY MEDICAL CENTER"}, {"name": "subject", "value": "STIMULANTS (DRUGS)"}, {"name": "subject", "value": "CAFFEINE"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "SLEEP"}, {"name": "subject", "value": "RESEARCH"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Benedict", "lastname": "CAREY"}], "original": "By BENEDICT CAREY"}, "document_type": "article", "pub_date": "2004-06-29T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Health & Fitness", "lead_paragraph": "A mother's love is like a drug, psychologists say, a potent substance that cements the parent-infant bond and has a profound impact on later development. But scientists have known little about how early mothering affects an infant biologically. If it is like a drug, what kind of drug?", "headline": {"main": "Addicted to Mother's Love: It's Biology, Stupid"}, "abstract": "Recent studies suggest direct relationship between early mothering and caregiving and later child development; Dr Francesca R D'Amato, CNR Institute of Neuroscience researcher, leads study on gene that inhibits separation anxiety in mice; study, published in journal Science, observed mice that did not develop bonds with mothers because they lacked genetic foundation to feel comfort; supports concept that maternal support acts as 'opiate,' which then tightens attachment bond with mother; other studies that support maternal attachment and child development described (M)", "print_page": "7", "word_count": 939, "_id": "4fd2535b8eb7c8105d7f9c93", "snippet": "A mother's love is like a drug, psychologists say, a potent substance that cements the parent-infant bond and has a profound impact on later development.     But scientists have known little about how early mothering affects an infant biologically....", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2004/06/29/health/addicted-to-mother-s-love-it-s-biology-stupid.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "D'AMATO, FRANCESCA R"}, {"name": "organizations", "value": "CNR INSTITUTE OF NEUROSCIENCE"}, {"name": "organizations", "value": "SCIENCE"}, {"name": "subject", "value": "GENETICS AND HEREDITY"}, {"name": "subject", "value": "CHILDREN AND YOUTH"}, {"name": "subject", "value": "RESEARCH"}, {"name": "subject", "value": "TESTS AND TESTING"}, {"name": "subject", "value": "FAMILIES AND FAMILY LIFE"}, {"name": "subject", "value": "MICE"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Benedict", "lastname": "CAREY"}], "original": "By BENEDICT CAREY"}, "document_type": "article", "pub_date": "2004-06-29T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Health & Fitness", "lead_paragraph": "Laurie Coots, a marketing executive who flies to meetings in other countries twice a week, spent years trying to conquer sleepless nights and chronic jet lag. But nothing worked, she says, and every day was a struggle to stay awake. ''It was debilitating,'' said Ms. Coots, 46, who is from Los Angeles. ''I couldn't give an effective presentation because I was always shaky and nervous from being amped up on caffeine and stimulants.''", "headline": {"main": "Wakefulness Finds a Powerful Ally"}, "abstract": "Modafinil, drug manufactured by Cephalon and sold as Provigil, enables people to go for extended periods of time without sleep; modafinil, which was first discovered in 1970's as treatment for narcolepsy, is now approved by Food and Drug Administration for additional use in treating obstructive sleep apnea and as aid for other sleep problems; off-label uses for drug continue to grow; theories on how modafinil works on brain are described, but scientists are uncertain how drug actually works; concerns over abuse of modafinil discussed; photo; drawings (L)", "print_page": "1", "word_count": 2171, "_id": "4fd2a2d38eb7c8105d888585", "snippet": "Laurie Coots, a marketing executive who flies to meetings in other countries twice a week, spent years trying to conquer sleepless nights and chronic jet lag. But nothing worked, she says, and every day was a struggle to stay awake.    ''It was...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2004/06/29/health/wakefulness-finds-a-powerful-ally.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "organizations", "value": "CEPHALON INC"}, {"name": "subject", "value": "MODAFINIL (DRUG)"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "PROVIGIL (DRUG)"}, {"name": "subject", "value": "SLEEP"}, {"name": "subject", "value": "NARCOLEPSY"}, {"name": "subject", "value": "RESEARCH"}, {"name": "subject", "value": "APNEA (SLEEP DISORDER)"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Anahad", "lastname": "O'CONNOR"}], "original": "By ANAHAD O'CONNOR"}, "document_type": "article", "pub_date": "2004-06-29T00:00:00Z", "section_name": "Health"}], "meta": {"hits": 4, "offset": 0, "time": 35}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}